CROI 2023 TB research round up

Treatment Action Group (TAG) released an overview of TB research data reported at the 30th Conference on Retroviruses and Opportunistic Infections (CROI 2023) held on 19-22 February 2023 in Seattle, Washington, USA. Highlights include the much-anticipated results of the SimpliciTB trial; additional analyses of the two-month TB treatment regimen studied in the TRUNCATE-TB trial; and the first clinical trial data on sutezolid since 2012.

A summary of major findings and TAG’s analysis are available here.

To subscribe to the Weekly Newsletter of new posts, enter your email here:


By Treatment Action Group

Published: Feb. 27, 2023, 9:51 p.m.

Last updated: March 6, 2023, 10 p.m.

Print Share